{"id":"NCT00210210","sponsor":"Institut Bergoni√©","briefTitle":"Administration of Ketamine to Prevent the Post-operative Pain","officialTitle":"Effect of Ketamine, at the Induction and Its Maintenance to Prevent the Post-operative Pain: Clinical Trial in Cancerology","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-01-31","primaryCompletion":"2005-07-31","completion":"2005-12-31","firstPosted":"2005-09-21","resultsPosted":"2025-09-08","lastUpdate":"2025-09-08"},"enrollment":230,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Postoperative Pain","Breast Cancer"],"interventions":[{"type":"DRUG","name":"Ketamine","otherNames":[]},{"type":"DRUG","name":"Saline solution","otherNames":[]}],"arms":[{"label":"Ketamine Arm","type":"EXPERIMENTAL"},{"label":"Reference Arm","type":"SHAM_COMPARATOR"}],"summary":"The surgery of breast cancer is responsible for post-operative pain, needing in about 30% some morphine consumption; like that, the association of ketamine with general anaesthesia may decrease morphine's use and so its adverse effects. The purpose is to evaluate the analgesic effect of a receptor NMDA's antagonist ( ketamine)","primaryOutcome":{"measure":"Morphine Consumption (First 48 Post-operative Hours)","timeFrame":"within 48 hours following surgery","effectByArm":[{"arm":"Ketamine Arm","deltaMin":79,"sd":null},{"arm":"Reference Arm","deltaMin":77,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":1,"countries":["France"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":109},"commonTop":["Vomiting NOS","Nausea"]}}